Azincourt Energy
CVE:AAZAzincourt Energy Corp., an exploration and development company, focuses on the alternative fuels/alternative energy sector in Canada and Peru. It explores for uranium and lithium deposits, as well as other clean energy elements. The company owns interest in the East Preston project covering an area of approximately 25,000 hectares located in Saskatchewan, Canada; and the Big Hill Lithium project covering approximately an area of 7,500 hectares located in southwestern Newfoundland, Canada. The company was formerly known as Azincourt Uranium Inc. and changed its name to Azincourt Energy Corp. in October 2017. Azincourt Energy Corp. was incorporated in 2011 and is headquartered in Vancouver, Canada.
Aura Biosciences
NASDAQ:AURAAura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.
Cantel Medical
NYSE:CMDCantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.
Intercontinental Gold and Metals
CVE:ICAUIntercontinental Gold and Metals Ltd. engages in the gold and metals trading business in Canada and Bolivia. It is involved in the gold refining; and physical commodities marketing and trading operations. The company was formerly known as Geodex Minerals Ltd. and changed its name to Intercontinental Gold and Metals Ltd. in November 2017. Intercontinental Gold and Metals Ltd. was incorporated in 2017 and is headquartered in Toronto, Canada.
Playfair Mining
CVE:PLYPlayfair Mining Ltd., an exploration stage company, engages in the acquisition, exploration, and development of mineral properties. It explores for copper, zinc, and nickel. The company holds a 100% interest in the Grey River Tungsten property that consisting of various mineral claims covering an area of 1,750 hectares located in southern Newfoundland, Canada; and holds a 100% interest in the RKV Cu-Co-Ni Project located in in south-central Norway. It also holds interest in Folldal Project and Osterdalen Project property. The company was incorporated in 1988 and is based in Vancouver, Canada.